156 related articles for article (PubMed ID: 26925251)
1. Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.
Akdemir G; Verheul MK; Heimans L; Wevers-de Boer KV; Goekoop-Ruiterman YP; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman GM; Lard LR; Huizinga TW; Trouw LA; Allaart CF
RMD Open; 2016; 2(1):e000172. PubMed ID: 26925251
[TBL] [Abstract][Full Text] [Related]
2. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.
Akdemir G; Heimans L; Bergstra SA; Goekoop RJ; van Oosterhout M; van Groenendael JHLM; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PBJ; Grillet BAM; Huizinga TWJ; Allaart CF
Ann Rheum Dis; 2018 Jan; 77(1):111-118. PubMed ID: 28970207
[TBL] [Abstract][Full Text] [Related]
4. A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.
Heimans L; Wevers-de Boer KV; Visser K; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Speyer I; de Buck MP; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Jul; 73(7):1356-61. PubMed ID: 23716067
[TBL] [Abstract][Full Text] [Related]
5. Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).
Wevers-de Boer K; Visser K; Heimans L; Ronday HK; Molenaar E; Groenendael JH; Peeters AJ; Westedt ML; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
Ann Rheum Dis; 2012 Sep; 71(9):1472-7. PubMed ID: 22402145
[TBL] [Abstract][Full Text] [Related]
6. Determinants of reaching drug-free remission in patients with early rheumatoid or undifferentiated arthritis after one year of remission-steered treatment.
Wevers-de Boer KV; Heimans L; Visser K; Schouffoer AA; Molenaar ET; van Groenendael JH; Peeters AJ; Speyer I; Collée G; Huizinga TW; Allaart CF
Rheumatology (Oxford); 2015 Aug; 54(8):1380-4. PubMed ID: 25687553
[TBL] [Abstract][Full Text] [Related]
7. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.
Allaart CF; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Breedveld FC; Dijkmans BA;
Clin Exp Rheumatol; 2006; 24(6 Suppl 43):S-77-82. PubMed ID: 17083767
[TBL] [Abstract][Full Text] [Related]
8. Five-year outcomes of probable rheumatoid arthritis treated with methotrexate or placebo during the first year (the PROMPT study).
van Aken J; Heimans L; Gillet-van Dongen H; Visser K; Ronday HK; Speyer I; Peeters AJ; Huizinga TW; Allaart CF
Ann Rheum Dis; 2014 Feb; 73(2):396-400. PubMed ID: 23334213
[TBL] [Abstract][Full Text] [Related]
9. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.
van der Kooij SM; le Cessie S; Goekoop-Ruiterman YP; de Vries-Bouwstra JK; van Zeben D; Kerstens PJ; Hazes JM; van Schaardenburg D; Breedveld FC; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2009 Jul; 68(7):1153-8. PubMed ID: 18930988
[TBL] [Abstract][Full Text] [Related]
10. Comparison between low disease activity or DAS remission as treatment target in patients with early active rheumatoid arthritis.
Akdemir G; Markusse IM; Bergstra SA; Goekoop RJ; Molenaar ET; van Groenendael JHLM; Kerstens PJSM; Lems WF; Huizinga TWJ; Allaart CF
RMD Open; 2018; 4(1):e000649. PubMed ID: 29862045
[TBL] [Abstract][Full Text] [Related]
11. Four-month metacarpal bone mineral density loss predicts radiological joint damage progression after 1 year in patients with early rheumatoid arthritis: exploratory analyses from the IMPROVED study.
Wevers-de Boer KV; Heimans L; Visser K; Kälvesten J; Goekoop RJ; van Oosterhout M; Harbers JB; Bijkerk C; Steup-Beekman M; de Buck MP; de Sonnaville PB; Huizinga TW; Allaart CF
Ann Rheum Dis; 2015 Feb; 74(2):341-6. PubMed ID: 24285491
[TBL] [Abstract][Full Text] [Related]
12. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
[TBL] [Abstract][Full Text] [Related]
13. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Smolen JS; Van Der Heijde DM; St Clair EW; Emery P; Bathon JM; Keystone E; Maini RN; Kalden JR; Schiff M; Baker D; Han C; Han J; Bala M;
Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
[TBL] [Abstract][Full Text] [Related]
14. Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; van Zeben D; Kerstens PJ; Gerards AH; van Groenendael JH; Hazes JM; Breedveld FC; Allaart CF; Dijkmans BA
Ann Rheum Dis; 2007 Oct; 66(10):1356-62. PubMed ID: 17293364
[TBL] [Abstract][Full Text] [Related]
15. The association of treatment response and joint damage with ACPA-status in recent-onset RA: a subanalysis of the 8-year follow-up of the BeSt study.
van den Broek M; Dirven L; Klarenbeek NB; Molenaar TH; Han KH; Kerstens PJ; Huizinga TW; Dijkmans BA; Allaart CF
Ann Rheum Dis; 2012 Feb; 71(2):245-8. PubMed ID: 22110122
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of four dynamic treatment strategies in patients with anticitrullinated protein antibody-negative rheumatoid arthritis: a randomised trial.
Akdemir G; Markusse IM; Dirven L; Riyazi N; Steup-Beekman GM; Kerstens P; Lems WF; Huizinga T; Allaart CF
RMD Open; 2016; 2(1):e000143. PubMed ID: 27099776
[TBL] [Abstract][Full Text] [Related]
17. Automated joint space width quantification of hand and wrist joints: a proof of concept study.
Huo Y; Veldhuizen RD; van der Heijde DM; Besselink NJ; Jacobs JW; van Laar JM; Viergever MA; Vincken KL; Lafeber FP; de Hair MJ;
Clin Exp Rheumatol; 2016; 34(5 Suppl 101):S34-S39. PubMed ID: 27762190
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
19. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA).
Hetland ML; Ejbjerg B; Hørslev-Petersen K; Jacobsen S; Vestergaard A; Jurik AG; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Skjødt H; Pedersen JK; Majgaard O; Svendsen AJ; Ellingsen T; Lindegaard H; Christensen AF; Vallø J; Torfing T; Narvestad E; Thomsen HS; Ostergaard M;
Ann Rheum Dis; 2009 Mar; 68(3):384-90. PubMed ID: 18388160
[TBL] [Abstract][Full Text] [Related]
20. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; van Vollenhoven RF; Lundberg K
Ann Rheum Dis; 2016 Feb; 75(2):356-61. PubMed ID: 25550338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
